Sodium Ferulate for Injection
Function and Efficacy
The results of animal studies show that sodium ferulate can inhibit the production of malondialdehyde and thromboxane B2, reduce myocardial edema and the release of lactate dehydrogenase, and promote the production of 6-keto-prostaglandin F1α, and has anti-platelet aggregation, vasodilation and myocardial protection effects.
Ingredients
The main ingredient of this product is sodium ferulate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Sodium ferulicIngredients |
The results of animal studies show that sodium ferulate can inhibit the production of malondialdehyde and thromboxane B2, reduce myocardial edema and the release of lactate dehydrogenase, and promote the production of 6-keto-prostaglandin F1α, and has anti-platelet aggregation, vasodilation and myocardial protection effects. More |
24276-84-4 | 8 |
Appearance
Sodium ferulate for injection is off-white or light yellow loose lumps or powder.
Indication
Used as an adjuvant treatment for ischemic cardiovascular and cerebrovascular diseases.
Usage and Dosage
Intravenous drip, 0.1 g/time, once/day
Adverse Reactions
Occasionally, allergic rash reactions occur, which disappear after stopping the medication.
Precautions
Patients who are allergic to sodium ferulate for injection are contraindicated.
Special Population Medication
Precautions during pregnancy and lactation: Not suitable for use by pregnant women, use with caution by lactating women.
Storage
cool
Packaging Specification
0.1g*10 bottles
Manufacturer
Jincheng Haisi Pharmaceutical Co., Ltd.
-
Founded in:
1997-12-30 -
Address:
Wangtai, Jincheng City, Shanxi Province -
Tax NO.:
91140500111208832X -
Registered Funds:
148.512131 yuan -
Email: